Buscar

Filtros actuales:
Comenzar nueva busqueda
Añadir filtros:

Usa los filtros para afinar la busqueda.


Resultados 21-30 de 38.
Resultados por ítem:
Vista previaFecha de publicaciónTítuloAutor(es)Acceso
2023 Multidisciplinary Panel Consensus.pdf.jpg2024Multidisciplinary Panel Consensus for the Management of Patients with Type 2 Diabetes: A Delphi Study
Orozco-Beltrán, Domingo; Cebrián-Cuenca, Ana M.; Moreno-Pérez, Oscar; Campuzano-Ruiz, Raquel; Soler, Maria Jose; García de Lucas, M. Dolores
2022 Health care use.pdf.jpg2022Healthcare use among people with diabetes mellitus in Europe: a population-based cross-sectional study
Fuentes-Merlos, Álvaro; Quesada-Rico, José Antonio; Reina, Raúl; Orozco-Beltrán, Domingo
2019 health care experience iexpac diabetes (1).pdf.jpg2020Healthcare experience among patients with type 2 diabetes: A cross-sectional survey using the IEXPAC tool
Orozco-Beltrán, Domingo; Artola-Menéndez, Sara; Hormigo-Pozo, Antonio; Cararach-Salami, Daniel; Alonso-Jerez, Juan Luis; Álvaro-Grande, Epifanio; Villabrille-Arias, Covadonga; de Toro-Santos8, Francisco Javier; Galindo-Puerto, María José; Marín-Jiménez, Ignacio; Gómez-García, Antón; Ledesma-Rodriguez, Rocío; Fernández, Gonzalo; Ferreira de Campos, Karine
Early biomarkers of diabetic kidney disease. A focus on albuminuria and a new combination of antidiabetic agents.pdf.jpg8-jun-2020Early biomarkers of diabetic kidney disease. A focus on albuminuria and a new combination of antidiabetic agents
Carretero Gomez, Juana; Ena, Javier; Seguí-Ripoll, José Miguel; Carrasco-Sánchez, Francisco Javier; Gómez Huelgas, Ricardo; Mateos Polo, Lourdes; Varela Aguilar, Jose M.; Suárez Tembra, José M; Arévalo-Lorido, José Carlos
Endocrine disruption in Crohn’s disease Bisphenol A enhances.pdf.jpg2021Endocrine disruption in Crohn’s disease: Bisphenol A enhances systemic inflammatory response in patients with gut barrier translocation of dysbiotic microbiota products
Linares, Raquel; Fernández, Mariana F.; Gutiérrez, Ana; García-Villalba, Rocío; Suárez, Beatriz; Martínez-Blázquez, José Alberto; Caparrós, Esther; Tomás-Barberán, Francisco A.; Francés, Rubén
Efficacy and safety of insulin glargine 300 UmL (Gla-300) during hospitalization and therapy intensification at discharge in patients with insufficiently controlled type 2.pdf.jpg18-jul-2020Efficacy and safety of insulin glargine 300 U/mL (Gla-300) during hospitalization and therapy intensification at discharge in patients with insufficiently controlled type 2 diabetes: results of the phase IV COBALTA trial
Perez, Antonio; Carrasco-Sánchez, Francisco Javier; González, Carlos; Seguí-Ripoll, José Miguel; Trescolí, Carlos; Ena, Javier; Borrell, Mireia; Gomez Huelgas, Ricardo
Dysbiotic microbiota interactions in Crohn’s.pdf.jpg2021Dysbiotic microbiota interactions in Crohn’s disease
Caparrós, Esther; Wiest, Reiner; Scharl, Michael; Rogler, Gerhard; Gutiérrez Casbas, Ana; Yilmaz, Bahtiyar; Wawrzyniak, Marcin; Francés, Rubén
La obesidad es una enfermedad crónica..pdf.jpg26-jul-2020La obesidad es una enfermedad crónica. Posicionamiento del grupo de trabajo de Diabetes, Obesidad y Nutrición de la Sociedad Española de Medicina Interna (SEMI) por un abordaje centrado en la persona con obesidad
Carretero Gómez, J.; Ena, J.; Arévalo-Lorido, José Carlos; Seguí-Ripoll, José Miguel; Carrasco-Sánchez, Francisco Javier; Gómez-Huelgas, R.; Pérez Soto, M.I.; Delgado Lista, J.; Pérez Martínez, P.
Enzyme replacement therapy for the treatment of Hunter disease A systematic review with narrative synthesis and meta-analysis.pdf.jpg21-jul-2020Enzyme replacement therapy for the treatment of Hunter disease: A systematic review with narrative synthesis and meta-analysis
Wikman-Jorgensen, Philip Erick; López Amorós, Ana; Peris García, Jorge; Esteve Atienzar, Pedro Jesús; Cañizares Navarro, Ruth; Asensio Tomás, Maria Luisa; Seguí-Ripoll, José Miguel; Bonet, David; Esteban-Giner, María José; Robert, Jaqueline; Giner-Galvañ, Vicente
Bacterial antigen translocation and age as BMI-independent.pdf.jpg2020Bacterial antigen translocation and age as BMI-independent contributing factors on systemic inflammation in NAFLD patients
Gómez-Hurtado, Isabel; Gallego-Durán, Rocío; Zapater, Pedro; Ampuero, Javier; Aller, Rocío; Crespo, Javier; Arias-Loste, María Teresa; García-Monzón, Carmelo; Bellot, Pablo; González-Rodríguez, Águeda; Juanola, Oriol; Romero Gómez, Manuel; Francés, Rubén